YS was appointed to the role of President, Canada Pharmaceuticals in February 2018 and is responsible for all pharmaceutical operations for GSK in Canada. He currently sits on the Canadian Country Management Board representing the Pharma business as well as being a prominent member of the Pharma Leadership Team.
Josée Gravelle is a member of the Canadian Pharma Leadership team and was appointed to General Counsel for the Canadian Pharma Organization in May 2013. Her main responsibility is to lead the Canadian Corporate and Legal Affairs team. Josée is also a member of the North American Legal Operating Committee.
Nicole Stuart has been with GSK since 2012 and was appointed Human Resources Country Head in January 2017. Nicole is responsible for leading the Canadian Human Resources team, who support all of the GSK business units across the country – Pharma, Consumer Healthcare, Biologicals, ViiV Healthcare, GMS and Support Functions – to deliver value to our patients, consumers and employees. Nicole is a member of the Canadian Country Management Board.
Eric Moreau is Site Director at Sainte-Foy (Canada) within GSK’s Vaccines. In his role, Eric leads site operations to ensure the reliable supply of our vaccines to patients, always in the respect of the highest standards.
Rupa was appointed to the role of Vice President and General Manager, Canada Consumer Healthcare (CH) in February of 2018 and is responsible for all CH operations for GSK in Canada. She sits on the Canadian Country Management Board representing the CH business and is also a member of the North American Growth Team (NAGT).
Dacia was appointed to the role of General Manager for ViiV Healthcare Canada in November 2019. With over 20 years of pharma experience and 16 years in the HIV therapeutic area, Dacia brings a wide range of skills and expertise to her role.
Andrew Ehrat holds the position of Site Director at Mississauga (Canada) within the global Pharmaceutical Supply Chain. In this role, Andrew leads the manufacturing and packaging of products in the Pharma, Consumer and ViiV Healthcare supply chains. Andrew also sits as a member of GSK's Canadian Country Management Board.